Tags : Licensed

NHS England Signs an Agreement with Vertex to Access All

Shots: The agreement allows CF patients aged ≥2yrs.with two copies of F508del mutation in CFTR gene to access Orkambi (lumacaftor/ivacaftor) and CF patients aged ≥12yrs. with either two or one copy of F508del mutation and copy of one of the other 14 licensed mutations to access Symkevi (tezacaftor/ivacaftor) in combination with ivacaftor in England The […]Read More